Publication
Number of items: 6.
None
Commercial software upgrades may significantly alter Perfusion CT parameter values in colorectal cancer. (2010)
V. Goh,
M. Shastry,
A. Engledow,
J. Reston,
J. Peck,
R. Endozo,
M. Rodriguez-Justo,
S.A. Taylor
and
S. Halligan
Do CEC guidelines under-utilise the full potential of increasing kVp as a dose-reducing tool? (2003)
P. Doherty,
D. O'Leary
and
Patrick C. Brennan
Assessment of the spatial pattern of colorectal tumour perfusion estimated at perfusion CT using two-dimensional fractal analysis. (2009)
V. Goh,
B. Sanghera,
D. Wellsted,
J. Sundin
and
S. Halligan
Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study. (2009)
V. Goh,
S. Halligan,
D. Wellsted
and
C.I. Bartram
Restricted
AI-powered prostate cancer detection: a multi-centre, multi-scanner validation study. (2025)
Francesco Giganti,
Nadia Moreira da Silva,
Michael Yeung,
Lucy Davies,
Amy Frary,
Mirjana Ferrer Rodriguez,
Nikita Sushentsev,
Nicholas Ashley,
Adrian Andreou,
Alison Bradley,
Chris Wilson,
Giles Maskell,
Giorgio Brembilla,
Iztok Caglic,
Jakub Suchánek,
Jobie Budd,
Zobair Arya,
Jonathan Aning,
John Hayes,
Mark De Bono,
Nikhil Vasdev,
Nimalan Sanmugalingam,
Paul Burn,
Raj Persad,
Ramona Woitek,
Richard Hindley,
Sidath Liyanage,
Sophie Squire,
Tristan Barrett,
Steffi Barwick,
Mark Hinton,
Anwar R. Padhani,
Antony Rix,
Aarti Shah
and
Evis Sala
![]()
Comparative performance of MRI-derived PRECISE scores and delta-radiomics models for the prediction of prostate cancer progression in patients on active surveillance. (2021)
Nikita Sushentsev,
Leonardo Rundo,
Oleg Blyuss,
Tatiana Nazarenko,
Aleksandr Suvorov,
Vincent J. Gnanapragasam,
Evis Sala
and
Tristan Barrett
![]()